Why the study?
Does intrathecal nicardipine improve refractory vasospasm in pediatric aneurysmal subarachnoid haemorrhage?
Does intrathecal nicardipine improve refractory vasospasm in pediatric aneurysmal subarachnoid haemorrhage?
Intrathecal nicardipine may be a safe and effective treatment for refractory vasospasm in pediatric patients with aneurysmal subarachnoid hemorrhage.
Intrathecal nicardipine use in refractory pediatric basilar vasospasm remains experimental; leaves open need for prospective safety and efficacy data.
We present a case of aneurysmal subarachnoid haemorrhage in a preadolescent teenage patient from a right posterior inferior cerebellar artery origin aneurysm rupture. During coiling they had a re-rupture event with cerebral anoxia which necessitated decompressive craniectomy on bleed day three due to medically refractory intracranial hypertension. The patient then developed severe bilateral V4 and basilar vasospasm. In addition to blood pressure control and fluids, 4mg of intrathecal nicardipine was administered every eight hours into the ventriculostomy for 5 days. Vasospasm was markedly improved within 24 hours and resolved within two days. MRI did not show any focal vasospasm-related stroke. At 6-month follow up, the only neurological deficit was short-term memory loss. The outcome of this case highlights the potential for IT nicardipine to safely and effectively reduce paediatric vasospasm and avoid detrimental injury resulting from cerebral ischemia.
No takes yet. Share an insight, caveat, or question.
Toothman et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: